Finance

Lists
Why is ESLA down 8,49%?
Dive Deeper
ESLA:NASDAQ
Estrella Immunopharma Inc
0,38 $
-8,49%
(-0,035) 1D
0,40 $
+6,58% (+0,025)
After hours
Closed: 6 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ESLA...
Open
0,40 $
High
0,44 $
Low
0,37 $
Mkt. cap
16,33 մլն
Avg. vol.
3,80 մլն
Volume
140,93 հզր
52-wk high
3,01 $
52-wk low
0,24 $
EPS
-0,25 $
Beta
0,88
Shares outstanding
43,50 մլն
Open
0,40 $
High
0,44 $
Low
0,37 $
Mkt. cap
16,33 մլն
Avg. vol.
3,80 մլն
Volume
140,93 հզր
52-wk high
3,01 $
52-wk low
0,24 $
EPS
-0,25 $
Beta
0,88
Shares outstanding
43,50 մլն
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
26 րոպե առաջ
3 Internet Giants to Hold for the Next 10 Years
Investor's Business Daily
Investor's Business Daily
·
8 ժամ առաջ
Futures: Market Needs Repair; These Big Winners Are Broken
About Estrella Immunopharma Inc
CEO-
Employees-
Founded2006
HeadquartersԷմերիվիլ, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,15 մլն
25,41 հզր
1,40 մլն
1,40 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
648,51 հզր
587,78 հզր
891,79 հզր
684,02 հզր
Operating expense
4,80 մլն
613,20 հզր
2,29 մլն
2,08 մլն
Total operating expenses
4,80 մլն
613,20 հզր
2,29 մլն
2,08 մլն
Operating income
-4,80 մլն
-613,20 հզր
-2,29 մլն
-2,08 մլն
Other non operating income
-
-
-
-222,09 հզր
EBT including unusual items
-4,80 մլն
-613,20 հզր
-2,29 մլն
-2,31 մլն
EBT excluding unusual items
-4,80 մլն
-613,20 հզր
-2,29 մլն
-2,31 մլն
Income tax expense
-
-25,00
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,80 մլն
-613,17 հզր
-2,29 մլն
-2,31 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,13
-0,01
-
-0,05
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps